Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

NCT00079638 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia
Coronary Heart Disease
Atherosclerosis
Stroke
Diabetes

Interventions

DRUG: Niacin
DRUG: Atorvastatin
DRUG: Simvastatin
DRUG: Ezetimibe
DRUG: Rosuvastatin

Sponsor

Kos Pharmaceuticals